Emcure Pharmaceuticals Limited — Credit Ratings, 01-09-2026: Credit Rating

CARE Ratings Limited has reaffirmed Emcure Pharma's Long-term and Short-term bank facilities at CARE AA; Stable / CARE A1+. The stable outlook reflects the company's healthy business profile, diversified revenue of ₹9,322 Cr in FY26 (+18% YoY), and improved profitability with a 20% PBILDT margin. Strong capital structure and strategic acquisitions further supported the ratings.